Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News RXi Pharmaceuticals Corp RXII

Healthcare Biotechnology
"RXi Pharmaceuticals Corp is a clinical-stage RNAi company developing therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which address significant unmet medical needs."

Recent & Breaking News (NDAQ:RXII)

Magal Wins $10 Million in Orders to Secure and Maintain Critical Power Utility Sites in LatAm

PR Newswire May 10, 2016

RXi Pharmaceuticals to Present an Update on its Consumer Health Programs at the Society for Investigative Dermatology 75th Annual Meeting

PR Newswire May 4, 2016

RXi Pharmaceuticals and Thera Neuropharma Enter into an Exclusive License Agreement for RXi's Self-Delivering RNAi (sd-rxRNA®) Platform Targeting SOD1 to Develop Therapeutics for Neurodegenerative Diseases, such as ALS (Lou Gehrig's Disease)

PR Newswire May 3, 2016

RXi Pharmaceuticals Secures European Patent for Novel RNAi Platform

PR Newswire May 2, 2016

RXi Pharmaceuticals Announces Advancement of its Ophthalmology Franchise with Successful Topical Delivery of sd-rxRNA to the Cornea in an in vivo Corneal Wound Model

PR Newswire April 28, 2016

RXi Pharmaceuticals to Webcast First Quarter 2016 Financial Results on Thursday, May 12, 2016

PR Newswire April 27, 2016

RXi Pharmaceuticals to Present at 18th Annual TIDES: Oligonucleotide and Peptides Therapeutics Conference

PR Newswire April 25, 2016

RXi Pharmaceuticals to Present at the Association for Research in Vision and Ophthalmology 2016 Annual Meeting

PR Newswire April 18, 2016

RXi Pharmaceuticals Announces Reverse Stock Split

PR Newswire April 15, 2016

RXi Pharmaceuticals Strengthens Intellectual Property Portfolio for Dermal Indications

PR Newswire March 31, 2016

RXi Pharmaceuticals Reports Fourth Quarter and Year End 2015 Financial Results and Recent Corporate Highlights

PR Newswire March 30, 2016

RXi Pharmaceuticals to Present at the Oligonucleotide Therapeutics and Delivery Conference

PR Newswire March 28, 2016

RXi Pharmaceuticals To Webcast Fourth Quarter And Year End 2015 Financial Results On Wednesday, March 30, 2016

PR Newswire March 16, 2016

RXi Pharmaceuticals to Present at the 18th Annual BIO CEO & Investor Conference

PR Newswire January 26, 2016

RXi Pharmaceuticals Announces the Initiation of a Phase 2 Trial in Dermatology with Samcyprone for Cutaneous Warts

PR Newswire December 21, 2015

RXi Pharmaceuticals to Present at the 8th Annual Biotech Showcase 2016

PR Newswire December 14, 2015

RXi Pharmaceuticals Reports Third Quarter 2015 Financial Results and Business Highlights

PR Newswire November 12, 2015

RXi Pharmaceuticals Announces the Initiation of a Phase 1/2 Trial in Ophthalmology with RXI-109 for Retinal Scarring

PR Newswire November 5, 2015

RXi Pharmaceuticals to Webcast Third Quarter 2015 Financial Results on Thursday, November 12, 2015

PR Newswire October 29, 2015

StockNewsNow.com Publishes New SNNLive Video Interview with RXi Pharmaceuticals Corporation

Marketwired October 27, 2015